| BBH Etf | | | USD 167.37 0.34 0.20% |
This module uses fundamental data of VanEck Biotech to approximate its Piotroski F score. VanEck Biotech F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of VanEck Biotech ETF. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about VanEck Biotech financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
VanEck Biotech Altman Z Score,
VanEck Biotech Correlation,
Portfolio Optimization, as well as analyze
VanEck Biotech Alpha and Beta and
VanEck Biotech Hype Analysis.
At this time, it appears that VanEck Biotech's Piotroski F Score is Inapplicable. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
0.0
Piotroski F Score - Inapplicable
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | |
| Change In Outstending Shares | |
VanEck Biotech Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to VanEck Biotech is to make sure VanEck is not a subject of accounting manipulations and runs a healthy internal audit department. So, if VanEck Biotech's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if VanEck Biotech's financial numbers are properly reported.
About VanEck Biotech Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
About VanEck Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VanEck Biotech ETF's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VanEck Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of VanEck Biotech ETF based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf.
Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf: The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.